A detailed history of Clearstead Advisors, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Clearstead Advisors, LLC holds 82,757 shares of ZTS stock, worth $14.3 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
82,757
Previous 74,498 11.09%
Holding current value
$14.3 Million
Previous $12.9 Million 25.21%
% of portfolio
0.26%
Previous 0.22%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$172.58 - $196.48 $1.43 Million - $1.62 Million
8,259 Added 11.09%
82,757 $16.2 Million
Q2 2024

Aug 09, 2024

BUY
$145.54 - $178.83 $10.4 Million - $12.8 Million
71,430 Added 2328.23%
74,498 $12.9 Million
Q1 2024

May 14, 2024

BUY
$165.67 - $199.94 $14,081 - $16,994
85 Added 2.85%
3,068 $519,000
Q4 2023

Feb 12, 2024

BUY
$151.44 - $200.09 $7,420 - $9,804
49 Added 1.67%
2,983 $588,000
Q3 2023

Nov 13, 2023

SELL
$167.14 - $192.77 $50,643 - $58,409
-303 Reduced 9.36%
2,934 $510,000
Q3 2023

Nov 07, 2023

SELL
$167.14 - $192.77 $13,538 - $15,614
-81 Reduced 2.44%
3,237 $563,000
Q2 2023

Aug 07, 2023

BUY
$160.94 - $186.23 $196,507 - $227,386
1,221 Added 58.23%
3,318 $571,000
Q1 2023

May 09, 2023

BUY
$145.48 - $175.02 $88,306 - $106,237
607 Added 40.74%
2,097 $349,000
Q4 2022

Feb 14, 2023

SELL
$131.14 - $157.47 $9,310 - $11,180
-71 Reduced 4.55%
1,490 $218,000
Q3 2022

Nov 14, 2022

SELL
$148.29 - $182.55 $44,931 - $55,312
-303 Reduced 16.26%
1,561 $231,000
Q2 2022

Aug 12, 2022

BUY
$155.97 - $200.09 $14,973 - $19,208
96 Added 5.43%
1,864 $320,000
Q1 2022

May 04, 2022

BUY
$181.39 - $234.03 $33,738 - $43,529
186 Added 11.76%
1,768 $333,000
Q4 2021

Feb 14, 2022

BUY
$193.69 - $247.03 $46,098 - $58,793
238 Added 17.71%
1,582 $386,000
Q3 2021

Nov 12, 2021

SELL
$189.29 - $209.69 $68,333 - $75,698
-361 Reduced 21.17%
1,344 $261,000
Q2 2021

Aug 12, 2021

BUY
$155.9 - $187.99 $54,720 - $65,984
351 Added 25.92%
1,705 $318,000
Q1 2021

May 14, 2021

BUY
$144.0 - $169.39 $96,480 - $113,491
670 Added 97.95%
1,354 $213,000
Q4 2020

Feb 11, 2021

SELL
$157.07 - $174.35 $4,869 - $5,404
-31 Reduced 4.34%
684 $113,000
Q3 2020

Nov 12, 2020

BUY
$137.1 - $165.37 $4,250 - $5,126
31 Added 4.53%
715 $118,000
Q1 2020

May 14, 2020

SELL
$92.66 - $144.94 $164,193 - $256,833
-1,772 Reduced 72.15%
684 $80,000
Q4 2019

Feb 11, 2020

BUY
$116.25 - $133.25 $285,510 - $327,262
2,456 New
2,456 $325,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $80.6B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Clearstead Advisors, LLC Portfolio

Follow Clearstead Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Advisors, LLC with notifications on news.